<?xml version="1.0"?>
<Articles JournalTitle="Current Journal of Neurology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>14</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2016</Year>
        <Month>02</Month>
        <Day>20</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Journal Index</title>
    <FirstPage>1</FirstPage>
    <LastPage>1</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Iranian Journal of Neurology</FirstName>
        <LastName>Iranian Journal of Neurology</LastName>
        <affiliation locale="en_US">Official journal of Iranian Neurologyical Association</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>02</Month>
        <Day>20</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">&#xA0;No Abstract</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/996</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/996/264</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>14</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2015</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Effects of hydroalcoholic extract of Coriandrum sativum on oxidative damage in pentylenetetrazole-induced seizures in rats.</title>
    <FirstPage>59</FirstPage>
    <LastPage>66</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Karami</LastName>
        <affiliation locale="en_US">Student Research Committee, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahmoud</FirstName>
        <LastName>Hosseini</LastName>
        <affiliation locale="en_US">Neurocognitive Research Center AND Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Toktam</FirstName>
        <LastName>Mohammadpour</LastName>
        <affiliation locale="en_US">Neurogenic Inflammation Research Center AND Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ahmad</FirstName>
        <LastName>Ghorbani</LastName>
        <affiliation locale="en_US">Pharmacological Research Center of Medicinal Plants AND Department of Pharmacology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hamid Reza</FirstName>
        <LastName>Sadeghnia</LastName>
        <affiliation locale="en_US">Pharmacological Research Center of Medicinal Plants AND Department of Pharmacology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hassan</FirstName>
        <LastName>Rakhshandeh</LastName>
        <affiliation locale="en_US">Pharmacological Research Center of Medicinal Plants AND Department of Pharmacology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Farzaneh</FirstName>
        <LastName>Vafaee</LastName>
        <affiliation locale="en_US">Neurogenic Inflammation Research Center AND Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahdi</FirstName>
        <LastName>Esmaeilizadeh</LastName>
        <affiliation locale="en_US">Esfarayen Faculty of Medical Sciences, Esfarayen, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: An important role for oxidative stress, as a consequence of epileptic seizures, has been suggested. Coriandrum sativum has been shown that have antioxidant effects. Central nervous system depressant effects of C. sativum have also been reported. In this study, the effects of hydroalcoholic extract of aerial parts of the plants on brain tissues oxidative damages following seizures induced by pentylenetetrazole (PTZ) was investigated in rats.
Methods: The rats were divided into five groups and treated: (1) Control (saline), (2) PTZ (90 mg/kg, i.p.), (3-5) three doses (100, 500 and 1000 mg/kg of C. sativum extract (CSE) before PTZ. Latencies to the first minimal clonic seizures (MCS) and the first generalized tonic-clonic seizures (GTCS) were recorded. The&#xA0; cortical and hippocampal tissues were then removed for biochemical measurements.
Results: The extract significantly increased the MCS and GTCS latencies (P &lt; 0.01, P &lt; 0.001) following PTZ-induced seizures. The malondialdehyde (MDA) levels in both cortical and hippocampal tissues of PTZ group were significantly higher than those of the control animals (P &lt; 0.001). Pretreatment with the extract prevented elevation of the MDA levels (P &lt; 0.010&#x2013;P &lt; 0.001). Following PTZ administration, a significant reduction in total thiol groups was observed in both cortical and hippocampal tissues (P &lt; 0.050). Pretreatment with the 500 mg/kg of the extract caused a significant prevention of decreased in total thiol concentration in the cortical tissues (P &lt; 0.010).
Conclusion: The present study showed that the hydroalcoholic extract of the aerial parts of C. sativum possess significant antioxidant and anticonvulsant activities.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/569</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/569/233</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>14</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2015</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: Preliminary findings of a randomized-controlled trial.</title>
    <FirstPage>67</FirstPage>
    <LastPage>73</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Etemadifar</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohsen</FirstName>
        <LastName>Janghorbani</LastName>
        <affiliation locale="en_US">Department of Epidemiology and Biostatistics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: The aim of this preliminary study was to assess the safety and efficacy of high-dose oral vitamin D3 supplementation during pregnancy in women with multiple sclerosis (MS) in Isfahan, Iran.
Methods:In a single center open-label randomized, controlled clinical Phase I/II pilot study, 15 pregnant women with confirmed MS with low serum 25-hydroxyvitamin D (25(OH)D) levels were randomly allocated to receive either 50,000 IU/week vitamin D3 or routine care from 12 to 16 weeks of gestation till delivery. The main outcome measures were mean change in serum 25(OH)D levels, expanded disability status scale (EDSS) score, and number of relapse events during pregnancy and within 6 months after delivery.
Results: Average serum 25(OH)D level at the end of trial in vitamin D3 supplemented group was higher than routine care group (33.7 ng/mL vs. 14.6 ng/ml, P &lt; 0.050). In vitamin D3 group, the mean EDSS did not changed 6 months after delivery (P &gt; 0.050), whereas in routine care group, the mean EDSS increased from 1.3 (0.4) to 1.7 (0.6) (P &lt; 0.070). Women in vitamin D3 group appeared to have fewer relapse events during pregnancy and within 6 months after delivery. No significant adverse events occurred.
Conclusion:Adding high dose vitamin D3 supplementation during pregnancy to routine care of women with MS had significant effect on the serum 25(OH)D levels, EDSS and number of relapse events during pregnancy and within 6 months after delivery.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/568</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/568/234</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>14</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2015</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Effects of pyridoxine supplementation on severity, frequency and duration of migraine attacks in migraine patients with aura: A double-blind randomized clinical trial study in Iran.</title>
    <FirstPage>74</FirstPage>
    <LastPage>80</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Omid</FirstName>
        <LastName>Sadeghi</LastName>
        <affiliation locale="en_US">Food Security Research Center AND Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Morteza</FirstName>
        <LastName>Nasiri</LastName>
        <affiliation locale="en_US">Department of Research Committee, School of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Maghsoudi</LastName>
        <affiliation locale="en_US">Food Security Research Center AND Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Naseh</FirstName>
        <LastName>Pahlavani</LastName>
        <affiliation locale="en_US">Food Security Research Center AND Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Rezaie</LastName>
        <affiliation locale="en_US">Department of Research Committee, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Gholamreza</FirstName>
        <LastName>Askari</LastName>
        <affiliation locale="en_US">Food Security Research Center AND Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background:Migraine is a chronic disease that affects nearly 6% of men and 18% of women worldwide. There are various drugs, which can successfully decrease migraine symptoms and frequency of migraine attacks, but these drugs usually are expensive. Hence, this study aimed to assess the effects of pyridoxine&#xA0; supplementation on severity, frequency and duration of migraine attacks as well as headache diary results (HDR).
Methods:This double-blind randomized clinical trial study was conducted on 66 patients with migraine with aura (MA) in Khorshid and Emam Mosa Sadr clinics of Isfahan University of Medical Sciences, Iran, in 2013. Patients were randomly allocated to receive either pyridoxine supplements (80 mg pyridoxine per day) or placebo. Severity, frequency and duration of migraine attacks and HDR were measured at baseline and at the end of the study.
Results:Mean age of patients was 34.24 &#xB1; 9.44 years old. Pyridoxine supplementation led to a significant decrease in headache severity (-2.20 &#xB1; 1.70 compared with -1 &#xB1; 1.50; P = 0.007), attacks duration (-8.30 &#xB1; 12.60 compared with -1.70 &#xB1; 9.60; P = 0.030) and HDR (-89.70 &#xB1; 134.60 compared with -6.10 &#xB1; 155.50; P = 0.040) compared with placebo, but was not effective on the frequency of migraine attacks (-2.30 &#xB1; 4 compared with -1.20 &#xB1; 7.80; P = 0.510).
Conclusion:Pyridoxine supplementation in patients with MA was effective on headache severity, attacks duration and HDR, but did not affect the frequency of migraine attacks.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/567</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/567/235</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>14</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2015</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Comparison of serum vitamin D level in multiple sclerosis patients, their siblings, and healthy controls.</title>
    <FirstPage>81</FirstPage>
    <LastPage>85</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Ghazaleh</FirstName>
        <LastName>Eskandari</LastName>
        <affiliation locale="en_US">Brain and Spinal Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahsa</FirstName>
        <LastName>Ghajarzadeh</LastName>
        <affiliation locale="en_US">Brain and Spinal Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mir Saeed</FirstName>
        <LastName>Yekaninejad</LastName>
        <affiliation locale="en_US">Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Ali</FirstName>
        <LastName>Sahraian</LastName>
        <affiliation locale="en_US">MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Razieh</FirstName>
        <LastName>Gorji</LastName>
        <affiliation locale="en_US">Iranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Faezeh</FirstName>
        <LastName>Rajaei</LastName>
        <affiliation locale="en_US">Iranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Abbas</FirstName>
        <LastName>Norouzi-Javidan</LastName>
        <affiliation locale="en_US">Brain and Spinal Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Faridar</LastName>
        <affiliation locale="en_US">Department of Neurology, Houston Methodist Hospital, Weill Cornell Medical College, Houston, TX.</affiliation>
      </Author>
      <Author>
        <FirstName>Amirreza</FirstName>
        <LastName>Azimi</LastName>
        <affiliation locale="en_US">Brain and Spinal Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Multiple sclerosis (MS) is an autoimmune,&#xA0; neuro- inflammatory disease&#xA0; of&#xA0; central nervous system affecting physical, emotional, and cognitive aspects of patients. Association of vitamin D deficiency and MS has been shown in previous studies. The aim of this study was to evaluate serum vitamin D level in MS cases and their sex-matched healthy siblings (who are genetically near similar) and non-relative sex-matched healthy controls.
Methods: A total of 135 subjects enrolled in this case- control study. Group one (n = 45) consisted of patients with established MS. Group two (n = 45) included sex- matched healthy siblings of the group one and group three participants (n = 45) were non-relative sex- matched&#xA0; healthy&#xA0; controls.&#xA0; Demographic&#xA0; data&#xA0; (age, sex), level of education, daily sun exposure duration, and month of birth gathered for all. Serum sample of all participants was collected for 25-hydroxy vitamin D measurement.
Results: There was no significant difference between vitamin D level, sun exposure duration, education level, and season of birth in three evaluated groups. Mean vitamin D level was 8.2 &#xB1; 10.1 (nmol/l) in women and 13.3 &#xB1; 7 (nmol/l) in men (P = 0.001). There was a significant positive correlation between daily sun exposure duration and vitamin D level in whole participants (r = 0.28, P &lt; 0.001) as well as in MS patients (r = 0.32, P = 0.030). Mean vitamin D level was significantly lower&#xA0; in&#xA0; participants&#xA0; who&#xA0; have&#xA0; born&#xA0; in spring and summer.
Conclusion:&#xA0; Vitamin&#xA0; D&#xA0; deficiency&#xA0; is&#xA0; high&#xA0; among Iranian population as well as MS patients.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/566</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/566/236</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>14</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2015</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Comparison of frequencies of non motor symptoms in Indian Parkinson's disease patients on medical management versus deep brain stimulation: A case-control study.</title>
    <FirstPage>86</FirstPage>
    <LastPage>93</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Kandadai</FirstName>
        <LastName>Rukmini Mridula</LastName>
        <affiliation locale="en_US">Department of Neurology, Nizam's Institute of Medical Sciences, Autonomous University, Hyderabad, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Rupam</FirstName>
        <LastName>Borgohain</LastName>
        <affiliation locale="en_US">Department of Neurology, Nizam's Institute of Medical Sciences, Autonomous University, Hyderabad, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Shaik Afshan</FirstName>
        <LastName>Jabeen</LastName>
        <affiliation locale="en_US">Department of Neurology, Nizam's Institute of Medical Sciences, Autonomous University, Hyderabad, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Gaddamanugu</FirstName>
        <LastName>Padmaja</LastName>
        <affiliation locale="en_US">Department of Neurology, Nizam's Institute of Medical Sciences, Autonomous University, Hyderabad, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Vcs Srinivasarao</FirstName>
        <LastName>Bandaru</LastName>
        <affiliation locale="en_US">Department of Research, Yashoda Hospital Somajiguda Hyderabad, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Praveen</FirstName>
        <LastName>Ankathi</LastName>
        <affiliation locale="en_US">Department of Neurosurgery, Nizam's Institute of Medical Sciences, Autonomous University, Hyderabad, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Meena A</FirstName>
        <LastName>Kanikannan</LastName>
        <affiliation locale="en_US">Department of Neurology, Nizam's Institute of Medical Sciences, Autonomous University, Hyderabad, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammed Shujath</FirstName>
        <LastName>Ali Khan</LastName>
        <affiliation locale="en_US">Department of Neurology, Nizam's Institute of Medical Sciences, Autonomous University, Hyderabad, India.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Non motor symptoms (NMS) of idiopathic Parkinson&#x2019;s disease (PD) are a major cause of disability and recognition of these symptoms and treatment is important for comprehensive health care. Deep&#xA0;&#xA0; brain&#xA0;&#xA0; stimulation&#xA0;&#xA0; of&#xA0;&#xA0; bilateral&#xA0;&#xA0; subthalamic nucleus deep brain stimulation (STN DBS) has been shown to improve motor symptoms in PD and effects on NMS are unknown. To investigate the NMS among PD patients who underwent STN DBS.
Methods: We recruited prospectively 56 patients with PD, who had undergone bilateral STN DBS and 53 age and duration of illness&#xA0; matched PD patients on dopaminergic therapy (controls). NMS were assessed using 30 item questionnaire NMS Quest. These questions&#xA0; evaluated&#xA0; 9 domains, gastrointestinal, urinary,&#xA0; cardiovascular, sexual, cognition (apathy/attention/memory), anxiety/depression, hallucinations/delusions, sleep an dmiscellaneous. Comparison was done on individual symptoms as well as&#xA0; in&#xA0; various&#xA0; domains.&#xA0; This&#xA0; study&#xA0; was&#xA0; carried&#xA0; at Nizam&#x2019;s&#xA0; Institution&#xA0; of&#xA0; Medical&#xA0; Sciences&#xA0; and&#xA0; study period was from January 2011 to December 2012. 
Results:&#xA0; Patients&#xA0; who underwent STN&#xA0; DBS&#xA0; had&#xA0; a significantly lower&#xA0; mean&#xA0; total&#xA0; score&#xA0; on&#xA0; NMS&#xA0; quest (6.7&#xA0;&#xA0; &#xB1;&#xA0;&#xA0; 3.8) &#xA0; compared&#xA0;&#xA0; to&#xA0;&#xA0; controls&#xA0;&#xA0; (8.4&#xA0;&#xA0; &#xB1; &#xA0; 3.7) (P&#xA0;&#xA0; &lt;&#xA0;&#xA0; 0.00100).&#xA0; Symptoms&#xA0;&#xA0; in&#xA0;&#xA0; the&#xA0;&#xA0; domains&#xA0;&#xA0; of cardiovascular, gastrointestinal, sleep were significantly less&#xA0; &#xA0; frequent&#xA0; while&#xA0; sexual&#xA0; disturbances&#xA0; were significantly more frequent among patients compared to controls.&#xA0; On&#xA0; individual&#xA0; symptom&#xA0; analysis,&#xA0; nocturia (P&#xA0; &lt;&#xA0; 0.00010),&#xA0; unexplained&#xA0; pains&#xA0; (P&#xA0; &lt;&#xA0; 0.00010), nausea&#xA0; and&#xA0; vomiting,&#xA0; constipation,&#xA0; lightheadedness, depression, and insomnia were less prevalent, while sexual disturbances were significantly more common in STN DBS group compared to controls.
Conclusion: Bilateral STN DBS not only improves the motor symptoms but also improves many NMS in PD patients.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/565</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/565/237</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran Univety of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>16</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>10</Month>
        <Day>07</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The effect of swallowing rehabilitation on quality of life of the dysphagic patients with cortical ischemic stroke</title>
    <FirstPage>178</FirstPage>
    <LastPage>184</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Kadir</FirstName>
        <LastName>Bahcec&#x131;</LastName>
        <affiliation locale="en_US">Physical Medicine and Rehabilitation Clinic, Ankara Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Ebru</FirstName>
        <LastName>Umay</LastName>
        <affiliation locale="en_US">Physical Medicine and Rehabilitation Clinic, Ankara Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Ibrahim</FirstName>
        <LastName>Gundogdu</LastName>
        <affiliation locale="en_US">Physical Medicine and Rehabilitation Clinic, Ankara Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Eda</FirstName>
        <LastName>Gurcay</LastName>
        <affiliation locale="en_US">Physical Medicine and Rehabilitation Clinic, Ankara Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Erhan</FirstName>
        <LastName>Ozturk</LastName>
        <affiliation locale="en_US">Physical Medicine and Rehabilitation Clinic, Ankara Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Sibel</FirstName>
        <LastName>Al&#x131;cura</LastName>
        <affiliation locale="en_US">Otolaryngology-Head and Neck Surgery Clinic, Ankara Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>11</Month>
        <Day>17</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>08</Month>
        <Day>21</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Swallowing and swallowing-related quality of life studies following stroke were almost always performed by including both patients with brainstem and cortical involvement. It was aimed in this study to show the presence of dysphagia in patients with only cortical ischemic stroke and to investigate the interaction between dysphagia and quality of life as well as to evaluate the effect of a rehabilitation program in the acute phase.

Methods: Seventy-two patients with cortical stroke (between 0 and 30 days) and dysphagia were included. Swallowing function of patients was assessed by dysphagia screen questionnaire and fiberoptic endoscopic assessment. Also, functional impairment and swallowing quality of life were assessed. The swallowing rehabilitation program for 4 weeks was given to all patients.

Results: All patients demonstrated disorders related to oral phase (n = 69, 95.8%), pharyngeal phase (n = 4, 5.6%) or both phases. The swallowing function, swallowing quality of life and functional impairment were improved at the end of therapy.

Conclusion: Swallowing quality of life is severely affected in cortical hemispheric stroke patients and can be improved with an early rehabilitation program.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/1178</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/1178/353</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>16</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>10</Month>
        <Day>07</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Prognostic value of ictal onset patterns in postsurgical outcome of temporal lobe epilepsy</title>
    <FirstPage>185</FirstPage>
    <LastPage>191</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Jafar</FirstName>
        <LastName>Mehvari-Habibabadi</LastName>
        <affiliation locale="en_US">Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Basiratnia</LastName>
        <affiliation locale="en_US">Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Houshang</FirstName>
        <LastName>Moein</LastName>
        <affiliation locale="en_US">Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Zare</LastName>
        <affiliation locale="en_US">Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Majid</FirstName>
        <LastName>Barakatain</LastName>
        <affiliation locale="en_US">Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Yahya</FirstName>
        <LastName>Aghakhani</LastName>
        <affiliation locale="en_US">Department of Clinical Neurosciences, University of Calgary, Calgary, Canada</affiliation>
      </Author>
      <Author>
        <FirstName>Nasim</FirstName>
        <LastName>Tabrizi</LastName>
        <affiliation locale="en_US">Isfahan University of Medical Sciences, Isfahan, Iran&#xD;
Department of Neurology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>08</Month>
        <Day>07</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>08</Month>
        <Day>21</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: To investigate ictal onset patterns (IOP) in scalp electroencephalography (EEG) of patients with temporal lobe epilepsy (TLE) and their prognostic effect on the postoperative outcome.

Methods: We conducted a retrospective cohort study between 2011 and 2015 in our referral Epilepsy Surgery Center enrolling adult patients with refractory TLE and a visible epileptogenic lesion in magnetic resonance imaging (MRI), who underwent epilepsy surgery. Demographic, clinical and MRI findings were collected and ictal findings during video-EEG monitoring were reviewed in detail. The correlation between preoperative findings and the postsurgical outcome was analyzed.

Results: We reviewed 303 seizures in 93 patients. Rhythmic theta and rhythmic spike/sharp and wave were respectively the most common initial ictal pattern and late significant discharges. Engel class I outcome was observed in 88.2% of patients. Female sex, aura, the absence of secondary generalization, rhythmic theta as initial ictal pattern and concordance of ictal-interictal EEG findings were correlated with favorable 1-year postsurgical outcome.

Conclusion: Preoperative clinical and EEG findings can provide valuable information regarding postsurgical prognosis in TLE patients.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/1377</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/1377/354</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>16</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>10</Month>
        <Day>07</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Molecular changes in obese and depressive patients are similar to neurodegenerative disorders</title>
    <FirstPage>192</FirstPage>
    <LastPage>200</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Laleh</FirstName>
        <LastName>Habibi</LastName>
        <affiliation locale="en_US">Nanotechnology Research Center, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran&#xD;
Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Abbas</FirstName>
        <LastName>Tafakhori</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran&#xD;
Iranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Rasoul</FirstName>
        <LastName>Hadiani</LastName>
        <affiliation locale="en_US">Heavy Metals Analysis Lab., Food and Drug Laboratories Research Center, Food and Drug Organization, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Maserat-Mashhadi</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran&#xD;
Iranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zeinab</FirstName>
        <LastName>Kafrash</LastName>
        <affiliation locale="en_US">Center of Diabetes Screening, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Shahla</FirstName>
        <LastName>Torabi</LastName>
        <affiliation locale="en_US">Center of Diabetes Screening, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Azhdarzadeh</LastName>
        <affiliation locale="en_US">Nanotechnology Research Center, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Mohammad</FirstName>
        <LastName>Akrami</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences. Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Morteza</FirstName>
        <LastName>Mahmoudi</LastName>
        <affiliation locale="en_US">Nanotechnology Research Center, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran&#xD;
Center of Diabetes Screening, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Rasoul</FirstName>
        <LastName>Dinarvand</LastName>
        <affiliation locale="en_US">Nanotechnology Research Center, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>05</Month>
        <Day>29</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>09</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Neurodegenerative disorders (NDs) are categorized as multifactorial conditions with different molecular and environmental causes. Disturbance of important signaling pathways, such as energy metabolism and inflammation induced by environmental agents, is involved in the pathophysiology of NDs. It has been proposed that changes in the lifestyle and nutrition (metabolism) during mid-life could trigger and accumulate cellular and molecular damages resulting in NDs during aging.

Methods: In order to test the hypothesis, we investigated the expression level of two energy metabolism-related [forkhead box O1 (FOXO1) and forkhead box O3 (FOXO3A)] and two pro-inflammatory cytokines [interleukin 1&#x3B2; (IL-1&#x3B2;) and IL-6] genes, using quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR). Furthermore, changes in the ionic concentration of three essential heavy metals [iron (Fe), copper (Cu), and zinc (Zn)] by atomic absorption spectroscopy in patients with NDs, depression, obesity, and diabetes type II, were evaluated and compared with the results of normal individuals.

Results: More than half of the participants in obesity, depression, and ND groups had significant up-regulation of FOXO1 and FOXO3A, down-regulation of IL-1&#x3B2; and IL-6, and higher levels of Fe and Cu in their blood. This pattern of gene expression was not repeated in diabetic patients.

Conclusion: It could be concluded that individuals affected with different levels of obesity and depression have increased risk of developing NDs later in life, probably through changes in energy metabolism, inflammatory pathways, and ionic concentrations.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/1066</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/1066/355</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>16</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>11</Month>
        <Day>16</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Ten-year trend in stroke incidence and its subtypes in Isfahan, Iran during 2003-2013</title>
    <FirstPage>201</FirstPage>
    <LastPage>209</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ahmad</FirstName>
        <LastName>Bahonar</LastName>
        <affiliation locale="en_US">Isfahan Neurosciences Research Center, Alzahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Khosravi</LastName>
        <affiliation locale="en_US">Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Fariborz</FirstName>
        <LastName>Khorvash</LastName>
        <affiliation locale="en_US">Isfahan Neurosciences Research Center, Alzahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammadreza</FirstName>
        <LastName>Maracy</LastName>
        <affiliation locale="en_US">Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran</affiliatio